Portulaca oleracea L. aids calcipotriol in reversing keratinocyte differentiation and skin barrier dysfunction in psoriasis through inhibition of the nuclear factor κB signaling pathway

Psoriasis affects 2–4% of the population worldwide and its treatment is currently far from satisfactory. Calcipotriol and Portulaca oleracea have been reported to exhibit the capacity to inhibit inflammation in psoriatic patients and improve their clinical condition. However, the efficacy of a combi...

Descripción completa

Detalles Bibliográficos
Autores principales: ZHAO, HENGGUANG, LI, SHUANG, LUO, FULING, TAN, QIAN, LI, HUI, ZHOU, WEIKANG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280941/
https://www.ncbi.nlm.nih.gov/pubmed/25574190
http://dx.doi.org/10.3892/etm.2014.2116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280941/
https://www.ncbi.nlm.nih.gov/pubmed/25574190
http://dx.doi.org/10.3892/etm.2014.2116

Ejemplares similares